The chance of dangerous bleeding, such as in the brain or stomach, rises by about half for every 10 years of age, even without aspirin, and becomes much higher if the person also takes other painkillers like ibuprofen or has kidney or liver problems.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis quantifying the age-related increase in major bleeding risk across multiple population-based studies, stratified by decade of life and adjusted for comorbidities and medication use.
A systematic review and meta-analysis of prospective cohort studies and RCTs reporting major bleeding events (intracranial, GI, other) in adults aged 50–90+, stratified by 10-year age groups, with pooled relative risks adjusted for NSAID use, renal function, liver disease, anticoagulant use, and frailty indices.
A prospective cohort study can estimate the annual incidence of major bleeding by decade of age, controlling for medication use and comorbidities.
A prospective cohort study following 15,000 adults aged 50–89 without prior bleeding, stratified by 10-year age groups, with annual assessment of bleeding events, NSAID use, renal/liver function, and frailty status over 10 years, using standardized bleeding criteria (e.g., ISTH).
A case-control study can determine whether older age is more common among individuals who experienced major bleeding compared to matched controls.
A matched case-control study comparing 1,200 elderly patients hospitalized for major GI or intracranial bleeding to 2,400 age- and sex-matched controls without bleeding, assessing age group (50–59, 60–69, 70–79, 80+) and comorbidities via medical records.
A cross-sectional survey can estimate the prevalence of bleeding symptoms or history across age groups in a population.
A nationally representative cross-sectional survey of 10,000 adults aged 50+ assessing self-reported major bleeding events (past 5 years), age group, NSAID use, and chronic disease status via structured questionnaire and medical record verification.
An expert opinion can summarize existing evidence on age-related bleeding risk but cannot quantify it independently.
A narrative review by a panel of hematology and geriatrics experts summarizing published data on age-related bleeding trends, with no original data collection.